Comparing Bute and Firocoxib Safety (AAEP 2010)

The non-steroidal anti-inflammatory drug (NSAID) firocoxib had fewer side effects than phenylbutazone in horses after 42 days of treatment, according to scientists from Merial Limited who presented comparative research results at the 2010 Convention of the American Association of Equine Practitioners (AAEP), held Dec. 4-8 in Baltimore, Md.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners